89.53
price up icon0.61%   0.54
pre-market  Pre-mercato:  89.90   0.37   +0.41%
loading
Precedente Chiudi:
$88.99
Aprire:
$88.99
Volume 24 ore:
2.70M
Relative Volume:
0.79
Capitalizzazione di mercato:
$35.11B
Reddito:
$4.15B
Utile/perdita netta:
$535.20M
Rapporto P/E:
66.81
EPS:
1.34
Flusso di cassa netto:
$575.20M
1 W Prestazione:
+6.55%
1M Prestazione:
+3.71%
6M Prestazione:
+1.34%
1 anno Prestazione:
+39.89%
Intervallo 1D:
Value
$88.63
$89.76
Intervallo di 1 settimana:
Value
$84.25
$89.76
Portata 52W:
Value
$57.52
$93.25

Dexcom Inc Stock (DXCM) Company Profile

Name
Nome
Dexcom Inc
Name
Telefono
(858) 200-0200
Name
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Dipendente
10,300
Name
Cinguettio
@dexcom
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
DXCM's Discussions on Twitter

Confronta DXCM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
DXCM
Dexcom Inc
89.53 34.89B 4.15B 535.20M 575.20M 1.34
Medical Devices icon
ABT
Abbott Laboratories
126.35 220.16B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
105.84 157.03B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
400.69 154.21B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.97 119.08B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.49 46.93B 5.69B 4.15B 623.10M 6.95

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-16 Iniziato Truist Buy
2025-05-30 Iniziato Goldman Buy
2025-04-10 Iniziato Mizuho Outperform
2025-02-03 Aggiornamento Redburn Atlantic Neutral → Buy
2025-01-16 Aggiornamento Robert W. Baird Neutral → Outperform
2024-07-26 Downgrade JP Morgan Overweight → Neutral
2024-07-26 Downgrade Robert W. Baird Outperform → Neutral
2024-05-30 Iniziato Redburn Atlantic Neutral
2024-03-12 Iniziato RBC Capital Mkts Outperform
2023-05-30 Ripresa Morgan Stanley Equal-Weight
2023-04-17 Aggiornamento Raymond James Outperform → Strong Buy
2023-03-29 Iniziato UBS Buy
2023-01-26 Iniziato Wolfe Research Outperform
2022-10-18 Iniziato Barclays Equal Weight
2022-10-12 Iniziato Jefferies Buy
2022-07-15 Iniziato Bernstein Outperform
2022-03-02 Ripresa BofA Securities Buy
2022-02-03 Aggiornamento BTIG Research Neutral → Buy
2022-01-19 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-01-07 Aggiornamento Guggenheim Neutral → Buy
2021-10-18 Downgrade Guggenheim Buy → Neutral
2021-07-21 Ripresa Cowen Outperform
2021-05-28 Aggiornamento Wells Fargo Underweight → Equal Weight
2021-05-25 Iniziato Barclays Overweight
2021-04-15 Iniziato Atlantic Equities Overweight
2021-01-06 Aggiornamento UBS Neutral → Buy
2020-10-02 Downgrade Wells Fargo Equal Weight → Underweight
2020-05-27 Reiterato Piper Sandler Overweight
2020-05-14 Iniziato Wells Fargo Equal Weight
2020-03-05 Iniziato Citigroup Buy
2019-11-07 Reiterato Canaccord Genuity Buy
2019-11-07 Aggiornamento Guggenheim Neutral → Buy
2019-10-23 Iniziato Stifel Buy
2018-11-28 Iniziato UBS Neutral
2018-10-19 Aggiornamento Goldman Sell → Neutral
2018-09-12 Aggiornamento Northland Capital Under Perform → Market Perform
2018-08-02 Reiterato Canaccord Genuity Buy
2018-07-02 Aggiornamento Raymond James Mkt Perform → Outperform
2018-06-08 Aggiornamento JP Morgan Neutral → Overweight
2018-05-11 Iniziato BofA/Merrill Buy
2018-05-03 Reiterato Canaccord Genuity Buy
2018-04-04 Iniziato Goldman Sell
2018-04-04 Iniziato Guggenheim Neutral
2018-03-23 Aggiornamento Robert W. Baird Neutral → Outperform
2018-01-04 Downgrade Northland Capital Market Perform → Under Perform
2017-09-28 Reiterato Wedbush Outperform
Mostra tutto

Dexcom Inc Borsa (DXCM) Ultime notizie

pulisher
01:24 AM

DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

01:24 AM
pulisher
Jul 28, 2025

Earnings To Watch: DexCom (DXCM) Reports Q2 Results Tomorrow - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom launches AI-powered meal logging for CGM users - MassDevice

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom Rolls Out AI-Powered Meal Logging for Stelo CGM - Medical Product Outsourcing

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom's AI-Powered Smart Food Logging: A Game-Changer in Glucose Management and Metabolic Health Tech - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom adds AI-powered food logging to Stelo glucose monitor By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio | DXCM Stock News - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio - DexCom Investor Relations

Jul 28, 2025
pulisher
Jul 28, 2025

Building a $33B Digital Health Juggernaut | Dexcom Chairman & CEO Kevin Sayer - iHeart

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in DexCom Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive DexCom Inc. stock higher in 2025Achieve rapid financial growth with expert help - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Dexcom leverages AI to tackle diabetes - Constellation Research

Jul 27, 2025
pulisher
Jul 26, 2025

Why DexCom Inc. stock attracts strong analyst attentionFree Top Growth Stock Recommendations - metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact? - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

Mizuho Lifts PT on DexCom (DXCM) to $100 From $95, Keeps an Outperform Rating - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

What drives DexCom Inc. stock pricePhenomenal wealth increase - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will DexCom Inc. stock split in the near futureFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 24% Impressive? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

DexCom Takes A Hit As Growth Meets New Headwinds - Finimize

Jul 23, 2025
pulisher
Jul 23, 2025

Is DexCom Inc. a good long term investmentFree Investment Case Studies - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about DexCom Inc. stockHigh-octane investment gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

DexCom Inc. Stock Analysis and ForecastFree Popular Stock Recommendations - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

We Think DexCom (NASDAQ:DXCM) Can Manage Its Debt With Ease - simplywall.st

Jul 22, 2025
pulisher
Jul 21, 2025

DexCom: Delivering Consistent Growth (NASDAQ:DXCM) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

Still Too Pricey? Dexcom’s Double-Digit Growth May Not Be Enough (DXCM) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

Are Medical Stocks Lagging DexCom (DXCM) This Year? - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years - AOL.com

Jul 20, 2025

Dexcom Inc Azioni (DXCM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Dexcom Inc Azioni (DXCM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
FOLETTA MARK G
Director
Jul 15 '25
Sale
85.17
2,750
234,217
53,871
Brown Michael Jon
EVP, Chief Legal Officer
Jul 15 '25
Sale
86.03
500
43,015
94,602
$77.74
price up icon 0.17%
medical_devices PHG
$25.66
price down icon 1.91%
medical_devices EW
$78.49
price down icon 1.89%
medical_devices STE
$226.53
price down icon 1.71%
$292.27
price up icon 0.71%
Capitalizzazione:     |  Volume (24 ore):